Cargando...
Darbepoetin as a Neuroprotective Agent in Mild Neonatal Encephalopathy: A Randomized, Placebo Controlled, Feasibility Trial
OBJECTIVE: To assess the feasibility and safety of one dose of Darbepoetin alpha (Darbe) administered to neonates ≥34 weeks with mild neonatal encephalopathy (NE) METHODS: Randomized, masked, placebo-controlled study including neonates ≥34 weeks gestation with mild NE. Neonates were randomized to re...
Guardado en:
| Publicado en: | J Perinatol |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8238874/ https://ncbi.nlm.nih.gov/pubmed/33986477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41372-021-01081-y |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|